Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor

Curr Oncol. 2023 Jun 4;30(6):5448-5455. doi: 10.3390/curroncol30060412.

Abstract

Testicular germ cell tumors (TGCTs) are the leading cause of cancer-related death in males between the ages of 20 and 40. In the advanced stages, the combination of cisplatin-based chemotherapy and surgical excision of the remaining tumor can cure many of these patients. Vascular procedures may be required during retroperitoneal lymph node dissection (RPLND) in order to achieve the complete excision of all residual retroperitoneal masses. Careful assessment of pre-operative imaging and the identification of patients who could benefit from additional procedures are important for minimizing peri- and postoperative complications. We report on a case of a 27-year-old patient with non-seminomatous TGCT, who successfully underwent post-chemotherapy RPLND with additional infrarenal inferior vena cava (IVC) and complete abdominal aorta replacement using synthetic grafts.

Keywords: aorta; retroperitoneal lymph node dissection; testicular germ cell tumors; vascular reconstruction; vena cava.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aorta, Abdominal / pathology
  • Aorta, Abdominal / surgery
  • Humans
  • Lymph Node Excision / methods
  • Male
  • Neoplasms, Germ Cell and Embryonal* / drug therapy
  • Neoplasms, Germ Cell and Embryonal* / surgery
  • Retroperitoneal Space / pathology
  • Retroperitoneal Space / surgery
  • Retrospective Studies
  • Testicular Neoplasms* / drug therapy
  • Testicular Neoplasms* / pathology
  • Testicular Neoplasms* / surgery
  • Vena Cava, Inferior / pathology
  • Vena Cava, Inferior / surgery
  • Young Adult

Supplementary concepts

  • Nonseminomatous germ cell tumor
  • Testicular Germ Cell Tumor

Grants and funding

This research received no external funding.